Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Norplant indemnity offer has support of Association of Reproductive Health Professionals.

Executive Summary

WYETH-AYERST NORPLANT INDEMNITY PROGRAM WINS SUPPORT OF ARHP, the Association of Reproductive Health Professionals said March 1. "Wyeth's indemnification program gives responsible health care providers the support and confidence they need to continue to recommend Norplant as a contraceptive option for their patients," ARHP said. Wyeth is offering to indemnify practitioners who use Norplant in accordance with approved labeling ("The Pink Sheet" Feb. 6, In Brief).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025861

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel